MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0093047
Akriti Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹53.84 Cr
▲ 12% YoY
Net profit · FY 2025
₹1.42 Cr
Net margin 2.6%
EBITDA · FY 2025
₹4.18 Cr
EBITDA margin 7.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹14.26 Cr
Satisfied ₹2.1 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
169
Provident fund records
About Akriti Pharmaceuticals Private Limited
Data last updated:
Akriti Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 November 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC143136. Its GSTIN is 27AAECA5313K1ZR (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jitendra Prasad and Priyanka Prasad.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No. 205 Thane Mint India Bulls Behind Hiranandani Meadows Near Hyde Park, Maharashtra, India – 400610.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.84 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹1.42 Cr (net margin 2.6%) and EBITDA of ₹4.18 Cr (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 19% over five years.
The company has about 169 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹14.26 Cr and satisfied charges of ₹2.1 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it.
Akriti Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0093047). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website akritipharma.com.
Company details
CIN U24230MH2003PTC143136
Registration Number 143136
Incorporation Date 14 November 2003
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0093047
Key People
Jitendra Prasad Director Priyanka Prasad Director Recognitions & Rankings of Akriti Pharmaceuticals
Contact details
Akriti Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is akritipharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No. 205 Thane Mint India Bulls Behind Hiranandani Meadows Near Hyde Park, Maharashtra, India – 400610
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Akriti Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Akriti Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Akriti Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Akriti Pharmaceuticals Private Limited, buy the company report.
Financials of Akriti Pharmaceuticals Private Limited
FY 2024 filings availableAkriti Pharmaceuticals Private Limited reported revenue of ₹53.84 Cr (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹53.84 Cr ▲ 12%
Net profit · FY 2025
₹1.42 Cr margin 2.6%
EBITDA · FY 2025
₹4.18 Cr margin 7.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 23%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 8%
5 years · compounded
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 12% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.42 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Akriti Pharmaceuticals Private Limited, buy the company report.
Board of directors of Akriti Pharmaceuticals Private Limited
Akriti Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Prasad Also directs: PPJ Pharma Private Limited | Director | 07 Sep 2015 | 11 Years 1 Months | Current |
| Priyanka Prasad Also directs: PPJ Pharma Private Limited | Director | 14 Nov 2003 | 22 Years 11 Months | Current |
Peer comparison
Akriti Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vim Meditech Private Limited | ₹53.98 Cr (FY 2024) | 13.0% | Ahmedabad, Gujarat, India | |||
| Akriti Pharmaceuticals Private Limitedthis company | ₹53.84 Cr (FY 2025) | ₹1.42 Cr | 2.6% | 12.0% | 169 | Thane, Maharashtra, India |
| Rasino Herbs Private Limited | ₹53.81 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Synchem Pharmaceuticals Private Limited | ₹53.59 Cr (FY 2025) | 4.0% | Indore, Madhya Pradesh, India | |||
| Vardhaman Remedies Private Limited | ₹53.36 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Akriti Pharmaceuticals Private Limited, buy the company report.
Auditor
Akriti Pharmaceuticals Private Limited is audited by MOHSIN SALIM KADAYA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MOHSIN SALIM KADAYA | FY 2024 | 177354 |
Shareholding
The shareholding of Akriti Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Akriti Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹14.26 Cr
Satisfied charges
₹2.1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Oct 2025 | 101199867 | Others | ₹8.56 Cr | Open | |
| 04 Mar 2024 | 100899905 | Hdfc Bank Limited | ₹4.5 Cr | Open | |
| 21 Nov 2022 | 100641472 | Others | ₹1.2 Cr | Open | |
| 11 Apr 2015 | 10571569 | Kotak Mahindra Bank Limited | ₹2.1 Cr | Satisfied |
To see the full charge records of Akriti Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Akriti Pharmaceuticals Private Limited has 3 court cases on record: 1 filed by Akriti Pharmaceuticals, 2 filed against it. All cases are disposed.
Total cases
3
Filed by the company
1
Filed against the company
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed by the company against Ashco Niulab Industries Ltd and 4 and 4 others | Disposed |
| District court, Pune, Maharashtra | Civil suit | Filed against the company by The State of Maharashtra | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Novartis Ag and Others | Disposed |
To see the full case history of Akriti Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Akriti Pharmaceuticals Private Limited has 5 MSME Form 1 returns on record between 2022 and 2024, listing 194 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Prachin Chemical | |||
| Richards Printing and Publishing Establishment | |||
| Bharat Rubber Works Private Limited | |||
| an individual supplier | |||
| Ideal Cures Private Limited |
To see the full MSME payment records of Akriti Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Akriti Pharmaceuticals Private Limited has a workforce of 169 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
169
Active EPFO establishments
1
Employee growth
9.74%
GST
Akriti Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECA5313K1ZR | Maharashtra | Active | 01 Jul 2017 |
| 10AAECA5313K1Z6 | Bihar | Active | 15 Feb 2021 |
To see the full GST registrations and return filing status of Akriti Pharmaceuticals Private Limited, buy the company report.
Recent activity
Akriti Pharmaceuticals Private Limited has 5 board changes on record since 2003: 2 appointments and 3 cessations. The latest: Jitendra Prasad ceased to be Additional Director on 30 Sep 2015.
Charges
A charge with Others amounted to Rs. 856.00 Lakh with Charge ID 101199867 was registered on 28 Oct 2025.
Charges
A charge registered on 11 Apr 2015 via Charge ID 10571569 with Kotak Mahindra Bank Limited was fully satisfied on 25 Sep 2025.
AGM
Akriti Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 450.00 Lakh registered on 04 Mar 2024 with Charge ID 100899905 was modified on 14 Aug 2024.
Filing
Akriti Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 450.00 Lakh with Charge ID 100899905 was registered on 04 Mar 2024.
Charges
A charge with Others amounted to Rs. 120.00 Lakh with Charge ID 100641472 was registered on 21 Nov 2022.
Ceased
Jitendra Prasad ceased to be Additional Director.
Appointed
Jitendra Prasad was appointed as Director.
Ceased
Madhurendra Kumar ceased to be Director.
Ceased
Madhurendra Vashist Narayan Singh Kumar ceased to be Director.
Charges
A charge with Kotak Mahindra Bank Limited of Rs. 210.00 Lakh registered on 11 Apr 2015 with Charge ID 10571569 was modified on 12 Jun 2015.
3 earlier events are in the company report.
Frequently asked questions
Akriti Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 November 2003 (23+ years old) and is registered under CIN U24230MH2003PTC143136.
Akriti Pharmaceuticals has 2 current directors:
- Jitendra Prasad - Director
- Priyanka Prasad - Director
The latest financial statements of Akriti Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Akriti Pharmaceuticals is 27AAECA5313K1ZR, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 10AAECA5313K1Z6 (Bihar).
The CIN (Corporate Identification Number) of Akriti Pharmaceuticals is U24230MH2003PTC143136. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Akriti Pharmaceuticals has 3 court cases on record: 1 filed by the company and 2 filed against it.
Akriti Pharmaceuticals was incorporated on 14 November 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Akriti Pharmaceuticals by revenue are Vim Meditech Private Limited, Rasino Herbs Private Limited, Synchem Pharmaceuticals Private Limited, Vardhaman Remedies Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jitendra Prasad ceased to be Additional Director on 30 Sep 2015. Jitendra Prasad was appointed as Director on 07 Sep 2015. Madhurendra Kumar ceased to be Director on 07 Sep 2015. Akriti Pharmaceuticals has 5 board changes on record in total.
Yes, Akriti Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0093047).
Akriti Pharmaceuticals has 5 MSME Form 1 returns on record between 2022 and 2024, listing 194 overdue payments to 9 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Akriti Pharmaceuticals can be reached through the website akritipharma.com. Its registered office is in Thane, Maharashtra, India.